Enger S - Search Results

1

Abnormal atrial activation in young patients with lone atrial fibrillation.

Holmqvist F, Olesen MS, Tveit A, Enger S, Tapanainen J, Jurkko R, Havmöller R, Haunsø S, Carlson J, Svendsen JH, Platonov PG. Holmqvist F, et al. Among authors: enger s. Europace. 2011 Feb;13(2):188-92. doi: 10.1093/europace/euq352. Epub 2010 Sep 23. Europace. 2011. PMID: 20864492

2

Non-invasive evaluation of the effect of metoprolol on the atrioventricular node during permanent atrial fibrillation.

Corino VD, Sandberg F, Platonov PG, Mainardi LT, Ulimoen SR, Enger S, Tveit A, Sörnmo L. Corino VD, et al. Among authors: enger s. Europace. 2014 Nov;16 Suppl 4:iv129-iv134. doi: 10.1093/europace/euu246. Europace. 2014. PMID: 25362163 Clinical Trial.

3

Atrial fibrillation and antithrombotic therapy in a 75-year-old population.

Tveit A, Abdelnoor M, Enger S, Smith P. Tveit A, et al. Among authors: enger s. Cardiology. 2008;109(4):258-62. doi: 10.1159/000107789. Epub 2007 Sep 17. Cardiology. 2008. PMID: 17873490

4

Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.

Ulimoen SR, Enger S, Carlson J, Platonov PG, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A. Ulimoen SR, et al. Among authors: enger s. Am J Cardiol. 2013 Jan 15;111(2):225-30. doi: 10.1016/j.amjcard.2012.09.020. Epub 2012 Oct 27. Am J Cardiol. 2013. PMID: 23111138 Clinical Trial.

5

Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.

Corino VD, Ulimoen SR, Enger S, Mainardi LT, Tveit A, Platonov PG. Corino VD, et al. Among authors: enger s. J Cardiovasc Electrophysiol. 2015 Feb;26(2):137-41. doi: 10.1111/jce.12580. Epub 2014 Dec 2. J Cardiovasc Electrophysiol. 2015. PMID: 25367150 Clinical Trial.

6

Non-invasive assessment of the effect of beta blockers and calcium channel blockers on the AV node during permanent atrial fibrillation.

Sandberg F, Corino VD, Mainardi LT, Ulimoen SR, Enger S, Tveit A, Platonov PG, Sörnmo L. Sandberg F, et al. Among authors: enger s. J Electrocardiol. 2015 Sep-Oct;48(5):861-6. doi: 10.1016/j.jelectrocard.2015.07.019. Epub 2015 Jul 26. J Electrocardiol. 2015. PMID: 26275982 Clinical Trial.

7

Circadian variation of variability and irregularity of heart rate in patients with permanent atrial fibrillation: relation to symptoms and rate control drugs.

Corino VD, Platonov PG, Enger S, Tveit A, Ulimoen SR. Corino VD, et al. Among authors: enger s. Am J Physiol Heart Circ Physiol. 2015 Dec 15;309(12):H2152-7. doi: 10.1152/ajpheart.00300.2015. Epub 2015 Oct 23. Am J Physiol Heart Circ Physiol. 2015. PMID: 26497961 Free article.

8

Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects.

Johansen OE, Brustad E, Enger S, Tveit A. Johansen OE, et al. Among authors: enger s. Cardiovasc Diabetol. 2008 Sep 28;7:28. doi: 10.1186/1475-2840-7-28. Cardiovasc Diabetol. 2008. PMID: 18822173 Free PMC article.

9

Impact of atrial fibrillation on NT-proBNP levels in a 75-year-old population.

Ulimoen SR, Enger S, Tveit A. Ulimoen SR, et al. Among authors: enger s. Scand J Clin Lab Invest. 2009;69(5):579-84. doi: 10.1080/00365510902853305. Scand J Clin Lab Invest. 2009. PMID: 19391062

10

Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly.

Berge T, Ulimoen SR, Enger S, Arnesen H, Seljeflot I, Tveit A. Berge T, et al. Among authors: enger s. Scand J Clin Lab Invest. 2013;73(4):326-33. doi: 10.3109/00365513.2013.780093. Epub 2013 Apr 16. Scand J Clin Lab Invest. 2013. PMID: 23586783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters